Increased tumorigenicity and resistance to antibody lysis of human colon tumor cells xenografted in congenitally athymic mice. 1979

M B Tompkins, and G V Rama Rao, and W A Tompkins

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M B Tompkins, and G V Rama Rao, and W A Tompkins
November 1991, Digestive diseases and sciences,
M B Tompkins, and G V Rama Rao, and W A Tompkins
February 1986, Cancer,
M B Tompkins, and G V Rama Rao, and W A Tompkins
March 1979, The Journal of general virology,
M B Tompkins, and G V Rama Rao, and W A Tompkins
April 1987, Immunology letters,
M B Tompkins, and G V Rama Rao, and W A Tompkins
February 1990, Cancer research,
M B Tompkins, and G V Rama Rao, and W A Tompkins
April 1977, Journal of the National Cancer Institute,
M B Tompkins, and G V Rama Rao, and W A Tompkins
October 1991, Journal of the National Cancer Institute,
M B Tompkins, and G V Rama Rao, and W A Tompkins
November 1988, British journal of cancer,
M B Tompkins, and G V Rama Rao, and W A Tompkins
August 1993, Cancer letters,
M B Tompkins, and G V Rama Rao, and W A Tompkins
September 1994, Cancer research,
Copied contents to your clipboard!